9:30 a.m.–9:45 a.m. 

Call to Order

Vivian Ota Wang, Ph.D., FACMG, CGC
Executive Secretary, ACRWH 
Deputy Director, Office of Research on Women's Health (ORWH), NIH

9:45 a.m.–10:30 a.m. 

ORWH Director’s Report 

Janine A. Clayton, M.D., FARVO
Chair, ACRWH 
Associate Director for Research on Women’s Health, NIH  
Director, ORWH, NIH 

10:30 a.m.–11:00 a.m. 

NIH Inclusion Update

Dawn Corbett, M.P.H.
NIH Inclusion Policy Officer, Office of Extramural Research, NIH

11:00 a.m.–11:05 a.m. 

Introduction of the NIH Deputy Director for Program Coordination, Planning, and Strategic Initiatives

Tara A. Schwetz, Ph.D.
NIH Deputy Director, Program Coordination, Planning, and Strategic Initiatives, NIH
Director, Division of Program Coordination, Planning, and Strategic Initiatives (DPCPSI), OD, NIH

11:05 a.m.–11:20 a.m. 

Open Discussion  

Janine A. Clayton, M.D., FARVO
Chair, ACRWH 
Associate Director for Research on Women’s Health, NIH  
Director, ORWH, NIH 

11:20 a.m.–11:50 a.m. 

Enhancing Community Engagement at ORWH

Elizabeth Barr, Ph.D.
Social and Behavioral Scientist Administrator, ORWH, NIH 

11:50 a.m.–12:00 p.m. 

Group Photo 

12:00 p.m.–12:45 p.m. 

Lunch Break 

12:45 p.m.–1:45 p.m. 

NIH Director's Report

Monica M. Bertagnolli, M.D.
Director, NIH

1:45 p.m.–2:25 p.m. 

White House Women's Health Research Initiative Update

Carolyn Mazure, Ph.D.
White House Initiative on Women's Health Research Chair and Norma Weinberg Spungen and Joan Lebson Bildner Professor in Women’s Health Research, Professor of Psychiatry and Psychology, Yale University

2:25 p.m.–3:45 p.m. 

Panel: Middle-Life Health of Women and Menopause

Moderator: Chhanda Dutta, Ph.D.  
Chief, Clinical Gerontology Branch, Division of Geriatrics and Clinical Gerontology, National Institute on Aging, NIH

Women and Alzheimer’s Disease Risk Begins in Midlife During the Menopausal Transition: Implications for Prevention and Treatment

Roberta Diaz Brinton, Ph.D.  
Director, Center for Innovation in Brain Science, University of Arizona Health Sciences

Impact of the Midlife and Menopause on Bone Health: What We Know, What We Need to Learn

Sherri-Ann Burnett-Bowie, M.D., M.P.H.
Associate Professor of Medicine, Harvard Medical School

Timing of Menopausal Hormone Therapy and Reduction of All-Cause Mortality and Cardiovascular Disease

Howard Neil Hodis, M.D.
Harry J. Bauer and Dorothy Bauer Rawlins 
Professor of Cardiology, Professor of Medicine, Population and Public Health Sciences, and Molecular Pharmacology and Toxicology, Director of Atherosclerosis Research Unit

3:45 p.m.–4:05 p.m. 

Concept Clearance: NIH Office of Autoimmune Disease Research (OADR-ORWH) Notice of Special Interest (NOSI)

Victoria Shanmugam, MBBS, MRCP, FACR, CCD
Director, NIH Office of Autoimmune Disease Research in ORWH (OADR-ORWH), NIH 

4:05 p.m.–4:30 p.m. 

Open Discussion

Janine A. Clayton, M.D., FARVO
Chair, ACRWH 
Associate Director for Research on Women’s Health, NIH  
Director, ORWH, NIH 

4:30 p.m.–4:35 p.m. 

Closing Statement

Janine A. Clayton, M.D., FARVO
Chair, ACRWH 
Associate Director for Research on Women’s Health, NIH  
Director, ORWH, NIH